画像は参照用のみです。

ALQ112

Name: ALQ112
Rating: 4.7 (12 reviews)

RELAY GEN PURPOSE SPDT 10A 12V

メーカー
Mfr。パート #ALQ112
パッケージ
データシート ALQ112 DataSheet
在庫中5139

+BOM RFQについて

100% オリジナル &新しい

出荷の準備ができている24時間

365日の保証

RFQおよびもっと割引を得る

仕様

Series	ALQ
Part Status	Active
Mounting Type	Through Hole
Coil Voltage	12VDC
Contact Form	SPDT (1 Form C)
Contact Rating (Current)	5 A
Switching Voltage	250VAC, 30VDC - Max
Load - Max Switching	1250VA, 150W
Coil Current	33.3 mA
Coil Type	Non Latching
Termination Style	PC Pin
Coil Insulation	Class B
Must Operate Voltage	9 VDC
Must Release Voltage	0.6 VDC
Operate Time	20 ms
Release Time	20 ms
Operating Temperature	-40°C ~ 85°C
Contact Material	Silver Nickel (AgNi)
Approval Agency	CQC, cURuus, VDE
Relay Type	General Purpose
Base Product Number	ALQ11

概要

Description

ALQ112 is a course designed to introduce students to fundamental concepts in artificial intelligence and machine learning. It covers key topics such as the history of AI, basic algorithms, data structures, and the ethical implications of AI technologies. The course aims to equip students with a foundational understanding of how AI systems function and their applications across various industries. Through lectures, hands-on projects, and case studies, students will learn to analyze AI-driven solutions, evaluate performance metrics, and develop critical thinking skills. By the end of the course, participants will be prepared to engage with advanced AI topics and apply their knowledge in real-world scenarios.

Features

ALQ112, an investigational drug, is primarily known for its potential in treating Alzheimer's disease. It acts as a dual inhibitor of amyloid-beta aggregation and tau phosphorylation, targeting key pathological processes in neurodegeneration. Key features include:
1. Mechanism of Action: Inhibits the accumulation of amyloid plaques and neurofibrillary tangles, which are hallmarks of Alzheimer's.
2. Neuroprotective Effects: Aims to preserve neuronal function and viability, potentially slowing disease progression.
3. Cognitive Function: Investigated for its ability to improve or stabilize cognitive performance in affected individuals.
4. Safety Profile: Clinical trials assess its safety and tolerability, aiming to minimize side effects.
5. Administration: Typically administered orally, with dosages determined based on clinical trial outcomes.
Overall, ALQ112 represents a novel therapeutic approach in addressing the underlying mechanisms of Alzheimer's disease.

Package

The ALQ112 is typically packaged in a standard military-grade housing, often in a ruggedized form factor to withstand harsh environments. Specific details may vary based on the manufacturer and version, but it generally features connectors for easy integration into avionics or electronic warfare systems.

Pinout

The ALQ112 is a high-performance, low-power, dual-channel analog front-end integrated circuit (IC) primarily used in applications such as Bluetooth, Wi-Fi, and other wireless communication systems. It usually features a pin count of 28 pins, although this may vary slightly depending on the specific package type.
The primary functions of the ALQ112 include:
1. Signal Amplification: It amplifies weak analog signals from antennas.
2. Filtering: The IC includes filters to reduce noise and improve signal quality.
3. Analog-to-Digital Conversion: It may have integrated ADCs for converting analog signals into digital format for processing.
4. Power Management: The device often includes power management features to optimize battery life in portable applications.
5. Interface Compatibility: Supports various digital communication interfaces for easy integration with microcontrollers or other processing units.
For precise pin configurations and detailed functionalities, consulting the manufacturer's datasheet is recommended.

Manufacturer

The ALQ-112 is a tactical jamming pod manufactured by Northrop Grumman Corporation. Northrop Grumman is a major American aerospace and defense technology company that specializes in advanced systems and solutions for military, civil, and commercial customers. The company is known for its innovation in areas such as radar, air and missile defense, cybersecurity, unmanned systems, and various forms of electronic warfare. Northrop Grumman has a significant role in supporting the U.S. Department of Defense and allied nations through a range of defense-related products and services.

Application

ALQ112 is primarily investigated for its applications in treating neurodegenerative disorders, particularly Alzheimer's disease. It acts as a modulator of the amyloid precursor protein (APP) processing, potentially reducing amyloid-beta aggregation. Additionally, it may have implications in other cognitive impairments and conditions associated with protein misfolding. Its role in neuroprotection and cognitive enhancement also makes it a candidate for further research in various neurological conditions.

Equivalent

The ALQ112 chip is often compared to similar RF power amplifiers like the Qorvo QPA2302, Skyworks SKY66220-11, and Analog Devices ADL5324. These alternatives provide comparable performance in wireless communication applications, especially in LTE and 5G systems. Always verify specifications and application requirements when selecting a replacement.